Protective effect of trapidil and l-arginine against renal and hepatic toxicity induced by cyclosporine in rats

Renal Failure

Volumn 32, Issue 8, 2010, Pages 959-968

  Salem, Neveen A ^a   Salem, Emad A ^b   Maarouf, Aref M ^b   Kamel, Mostafa ^b   Elgalaly, Hazem ^b   Radwan, Mohamed ^c   El Dayem, Walid A Abd ^c   Eladl, Mahmoud ^b  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b ZAGAZIG UNIVERSITY   (Egypt)

^c ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

Cyclosporine; Hepatotoxicity; l arginine; Nephrotoxicity; Oxidative and nitrosative stress; Trapidil

Indexed keywords

ALANINE AMINOTRANSFERASE; ARGININE; ASPARTATE AMINOTRANSFERASE; CREATININE; CYCLOSPORIN; CYTOKINE; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; TRAPIDIL; TUMOR NECROSIS FACTOR ALPHA; UREA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; ENZYME BLOOD LEVEL; HISTOPATHOLOGY; INFLAMMATION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY PARENCHYMA; LABORATORY TEST; LIVER; LIVER DYSFUNCTION; LIVER FUNCTION; LIVER PROTECTION; NEPHROTOXICITY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; UREA BLOOD LEVEL;

ANIMALS; ARGININE; CYCLOSPORINE; DRUG-INDUCED LIVER INJURY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; MALE; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; TRAPIDIL; VASODILATOR AGENTS;

EID: 77955943477     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2010.501933     Document Type: Article

References (59)

1. Ponticelli C. Cyclosporine: From renal transplantation to autoimmune diseases. Ann. N.Y. Acad. Sci. 2005;1051:551-558.
2. Amudha G, Josephino A,Varalakshmi P. Role of lipoic acid in reducing the oxidative stress induced by cyclosporine. Clinica Chimica Acta. 2007;372(1-2):134-139.
3. Rezzani R. Exploring cyclosporine A-side effects and the protective role-played by antioxidants: The morphological and immunohistochemical studies, Histol. Histopathol. 2006;21:301-316.
4. de Mattos AM, Olyael AJ, Bennett WM. Pharmacology of immunosuppressive drugs. Renal Failure. 1996;18:453-460.
5. Kurus M, Esrefoglu M, Karabulut AB Sogutlu G, Kaya M, Otlu A. Oral L-arginine protects against cyclosporine-induced hepatoxicity in rats. Exp. Toxicol. Pathol. 2008;60(4-5): 411-419.
6. Atici A., Bozlu G, Turhan AH, et al. The role of trapidil on neuronal apoptosis in neonatal rat model of hypoxic ischemic brain injury. Early Human Develop. 2008;84(4):234-247.
7. Joner M, Finn AV, Fab A, Vimani R. Pathology of drug eluting stents in humans: Delayed heating and late thrombosis risk. J Am Coli Cardial. 2006;48:193-202.
8. Kawamura T, Tikitani T, Okajima Y, et al. Effect of trapidil on prostacyclin generation of arterial wall. Prostaglandins Med. 1980;5(2):113-121.
9. Suzuki Y, Yamaguchi K, Shimada S, Kitamure Y, Ohnishi H. Antithrombotic activity and the mechanism of action of trapidil. Prostaglandins Lekat Med. 1982;9(6):685-695.
10. Cheng Y, Liu P, Chen H, Zng F. Antiproliferative effects of trapidil in vascular smooth cells are associated by inhibition of MAPK and P34 (cdc 2) activity. J. Cardiovasc. Pharmacol. 2000;35(1):1-6.
11. Poon M, Cohen J, Siddiqui Z, Folton JT, Taubman MB. Trapidil inhibits monocyte chemoattractant protein-1 (MCP-1) and macrophage accumulation after ballon arterial injury in rabbits. Lab. Invest. 1999;79(11):1369-1375.
12. Bagdtoglu C, Saray A, Surucu HS, Ozturk H, Tamer L. Effect of trapidil in ischemia reperfusion injury of peripheral nerves. Neurosurgery. 2002;51:212-220.
13. Valdivielso JM, Blantz RC Acute renal failure: Is nitric oxide the bad guy? Antioxid. Redox. Signal. 2002;41(6):925-934.
14. Steven Y, Jung T, Klotz LD, Schewe T, Grune T, Sies H. Protein modification elicited by oxidized low density lipoprotein (LDL) in endothelial cell. Protection by (-)-epicatechin. Free Rad. Biol. Med. 2007;42:955-970.
15. Matsuno H, Stassen JM, Hoylaerts MF, Vermylen J, Deckmyn H. Fast and reproducible vascular neointima formation in the hamster carotid artery: Effect of trapidil and captopril. Thromb. Hemost. Dec. 1995;74(6):1591-1596.
16. Tsao PS, McEvoy LM, Rexler HD, Butcher EC, Cooke JP. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation. 1994;89(5):2176-2182.
17. Henry RJ. Clinical Chemistry, Principles and Technics. 2nd ed. Harper and Row;1974:625.
18. Searcy RI, Reardon JE, Foreman JA. Enzymatic serum urea determination. Am. J. Med. Technol. 1967;33:15-20.
19. Moshage H, Kok B, Huizenga JR, Jansen PLM. Nitric and nitrate determination in plasma: A critical evaluation. Clin. Chem. 1995;4(6):892-896.
20. Zajkowska JM, Hermanowska-Szpakowiez T, Pancewicz SA, Kondrusik M, Swlerzbinska R, Grygorezuk S. Serum concentration of TNF-a and IL-1b in patient with chronic hepatitis treated with interferon alpha: A preliminary report. Rocz. Akad. Med. Bialymst. 2002;47:276-286.
21. Chen W, Jin W, Cook M, Weiner HL, Wahl SM. Oral delivery of group A streptococcal cell walls augments circulating TGFbeta and suppresses streptococcal cell wall arthritis. J. Immunol. 1998;161(11):6297-6304.
22. Ono K, Matsumori A, Furukawa Y, Igata H, Shioi T, Matsushima SS. Prevention of myocardial reperfusion injury in rats by an antibody against monocyte chemotactic and activating factor/monocyte chemoattractant protein-1. Lab Invest. 1999;79(2):195-203.
23. Reitman S, Frankel S. The colorimetric method for determination of serum glutamic oxaloacetic transaminase and serum glutamic pyruvic transaminase. Am. J. Clin. Pathol. 1957;28: 56-63.
24. Hassoun EA, Stohs SJ. Cadmium induced production of superoxide anion and nitric oxide DNA single standard breaks and lactate dehydrogenase leakage in J. 774 A-1 cultures. Toxicology. 1996;112(3):219-226.
25. Babior BM, Kipnes RS, Curnutte ST. Biological defense mechanisms, the production by leukocytes of superoxide potential bactericidal agent. J. Clin. Invest. 1973;52(3):741-744.
26. Placer ZA, Cushman LL, Johnson BC. Estimation of lipid peroxidation (malondialdehyde) in biochemical systems. Anal. Biochem. 1966;16:359-365.
27. Chromy V, Fischer J. Photometric determination of total protein in lipemic sera. Clin. Chem. 1977;23(4):754-756.
28. Marklund SL. Pyrogallol autooxidation. In: Greenwold RA, ed. Handbook of Methods for Oxygen Radical Research. Boca Raton, FL: CRC Press; 1985:243-247.
29. Clairborne A. Catalase activity. In: Greenwold RA, ed. Handbook of Methods for Oxygen Radical Research. Boca, Ration, FL: CRC Press; 1985:283-284.
30. Prophet EB, Mills B, Arrington JB, Sobin LH. Laboratory Methods in Histotechnology. Washington, DC: American Registry of Pathology; 1992.
31. Steel RDG, Torrie JH. Principles and Procedures of Statistics: A Biometrical Approach. 2nd Ed.Singapore: McGraw-Hill; 1984, 4th print.
32. Duncan DB. Multiple range test and multiple F test. Biometrics. 1955;1:1-42.
33. Grub S, Persohn E, Trommer WE, Wolf AE. Mechanisms of cyclosporine A-induced apoptosis in rat hepatocyte primary cultures. Toxicol. Appl. Pharmacol. 2000;163:209-220.
34. Rezzani R. Cyclosporine A and adverse effects on organs: Histochemical studies. Prog. Histochem. Cytochem. 2004;39: 85-128.
35. Ramesh G, Reaves WB. TNF-a mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J. Clin. Invest. 2002;110(6):835-842.
36. Banas B, Luckow B, Moller M, et al. Chemokine and chemokine receptor expression in a novel human mesangial cell line. J. Am. Soc. Nephrol. 1999;10(11):2314-2322.
37. Funakoshi Y, Ichiki T, Shimokawa H, et al. Rho-kinase mediates angiotensin II-induced monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cells. Hypertension. 2001;38(1):100-111.
38. Buyukafsar K, Yazar A, Dusmez D, Ozturk H, Polat G, Levent A. Effect of trapidil an antiplatelet and vasodilator agent on gentamicin-induced nephrotoxicity in rats. Pharmacol. Res. 2001;44(4):321-328.
39. Turk G, Atessahin A, Sonmez M, Yuce A, Ceribasi AO. Lycopene protects against cyclosporine A-induced testicular toxicity in rats. Theriogenology. 2007; 67:778-785.
40. Colak T, Polat A, Bagdatoglu O, Kanik A, Turkmenoglu O, Aydin S. Effect of trapidil in ischemia/reperfusion injury on rat small intestine. J. Invest. Surg. 2003;16(3):167-176.
41. Kato Y, Tsuda T, Hosaka Y, et al. Effect of trapidil on effect or functions of monocytes related atherosclerotic plaque. Eur. J. Pharmacol. 2001;428(3):371-379.
42. Deguchi H, Takeya H, Wada H, et al. Dilazep an antiplatelet agent inhibits tissue factor expression in endothelial cells and monocytes. Blood. 1997;90(6):2345-2356.
43. Bonish D, Weber AA, Wittpoth M, Osinski M, Schror K. Antimitogenic effects of trapidil in coronary artery smooth muscle cells by direct activation of protein kinase A. Mol. Pharmacol. 1998;54:241-248.
44. Nieder J, Claus P, Auguntin W. Effect of trapidil on PG 12 and TXA2 synthesis in human umbilical viens perfused in vitro. Prostaglandins. 1995;49:311-318.
45. Ozaraz R, Tahan V, Aydin S, Uzun H, Kaya S, Senturk H. N-acetylcysteine attenuates alcohol-induced oxidative stress in the rat. World J. Gastroenterol. 2003;9:125-128.
46. Canoruc N, Cieck R, Atamer A, Dursun M, Turgut C, Guneli E. Protective effect of vitamin E selenium and alloporinol against stress induced ulcer formation in rats. Turk J. Med. Sci. 2001;31:199-203.
47. Durak H, Ozbek H, Elgun S. Cyclosporine reduces hepatic antioxidant capacity: Protective roles of antioxidants. Int. Immunopharmacol. 2004;4:469-473.
48. Crooke JP, Tsao PS. Cytoprotective effects of nitric oxide. Circulation. 1993;88:2451-2454.
49. Lee SK, Kim CS, Yang WS, Kim SB, Park SK, Park JS. Exogenous nitric oxide inhibitis tumor necrosis factor alpha or interleukin-1b induced monocyte chemoattractant protein-1 expression in human mesangial cells. Nephron. 2002;92(4):780-787.
50. Saad SY, Najjar TA, Daba MH, Al-Rikabi AC. Inhibition of nitric oxide synthase aggravates cisplatin-induced nephrotoxicity effect of 2-amino-4-methylpyridine. Chemotherapy. 2002;48(6): 309-315.
51. Mansour M, Daba MH, Gado A, Al-Rikabi A, Al-Majed A. Protective effect of L-arginine against nephrotoxicity induced by cyclosporine in normal rats. Pharmacol. Res. 2002;45(6): 441-446.
52. Tsao PS, Wang B, Buitrage R, Shyy JY, Cooke P. Nitric oxide regulate monocyte chemotactic protein-1. Circulation. 1997;96: 934-940.
53. Radi R, Becman JS, Bush KM, Freeman BA. Peroxynitrite oxidation of sulfhydryls: The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 1991;266:4244-4250.
54. Stamler JS, Simon DL, Osborne JA, et al. S-Nitrosylation of proteins with nitric oxide: Synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA. 1992;89:444-448.
55. Hogg N, Kalyanaramer B, Strnck A. Inhibition of low density lipoprotein oxidation by nitric oxide potential role in atherogenesis. FEBS Lett. 1993;334:170-174.
56. Clancy RM, Leszczynska P, Piziak J, Abramson SB. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on NADP oxidase. J Clin Invest. 1992;90:1116-1121.
57. Diao TJ, Yuan TY, Li YL. Immunologic role of nitric oxide in acute rejection of golden hamster for rat liver xenotransplantation. World J Gastroenterol. 2002;8:746-751.
58. Aikio O, Pokela ML, Hallman M. Exhaled and nasal nitric oxide in mechanically ventilated preterm and term newborns. Acta Pediatr. 2002;91:1078-1986.
59. Nakanishi H, Kaibori M, Teshima S, Yoshida H, Kwon AH, Kamiyama Y. Pirenldone inhibits the induction of I NOS stimulated by interleukin-1 beta at a step of NF-kB DNA binding in hepatocytes. J. Hepatol. 2004;41:730-736.